Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 58.1% in April

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decline of 58.1% from the March 31st total of 3,100 shares. Based on an average daily volume of 15,800 shares, the short-interest ratio is presently 0.1 days.

Cardio Diagnostics Stock Performance

NASDAQ:CDIOW opened at $0.03 on Wednesday. Cardio Diagnostics has a 12-month low of $0.02 and a 12-month high of $0.18. The stock’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.05.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.